BEAM THERAPEUTICS INC. - COMMON STOCK

Beam Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference

03 Aug 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus Conference

08 Jul 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference

25 May 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results

11 May 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Oral and Poster Presentations at 24th American Society of Gene and Cell Therapy Annual Meeting

27 Apr 2021 15:41:11 By Nasdaq GlobeNewswire

Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors for Precise Editing

20 Apr 2021 09:12:36 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Business and Pipeline Progress and Reports Fourth Quarter and Full Year 2020 Financial Results

15 Mar 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Appoints Amy Simon, M.D., Chief Medical Officer

15 Mar 2021 05:15:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Barclays 2021 Global Healthcare Conference

04 Mar 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Announces Acquisition of Guide Therapeutics

23 Feb 2021 07:34:34 By Nasdaq GlobeNewswire

Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors

19 Jan 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics Appoints Leading Healthcare Executive Kate Walsh to its Board of Directors

11 Jan 2021 05:30:00 By Nasdaq GlobeNewswire

Beam Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

05 Jan 2021 05:30:00 By Nasdaq GlobeNewswire